➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Colorcon
McKesson
Merck
Express Scripts

Last Updated: November 25, 2020

DrugPatentWatch Database Preview

Litigation Details for Avanir Pharmaceuticals Inc. v. Actavis South Atlantic LLC (D. Del. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Avanir Pharmaceuticals Inc. v. Actavis South Atlantic LLC (D. Del. 2011)

Docket   Start Trial Date Filed 2011-08-10
Court District Court, D. Delaware Date Terminated 2015-09-25
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties ACTAVIS INC.; ACTAVIS LLC; ACTAVIS SOUTH ATLANTIC LLC; ACTAVIS, INC.; AVANIR HOLDING COMPANY; AVANIR PHARMACEUTICALS INC.; CENTER FOR NEUROLOGICAL STUDY; DUANE MORRIS LLP; IMPAX LABORATORIES INC.; PAR PHARMACEUTICAL COMPANIES INC.; PAR PHARMACEUTICAL INC.; SANDOZ INC.; WATSON LABORATORIES INC.; WATSON PHARMA INC.; WATSON PHARMACEUTICALS INC.; WOCKHARDT LTD.; WOCKHARDT USA LLC
Patents 7,659,282; 8,227,484; RE38,115
Attorneys Adrienne G. Johnson; Amy E.L. Schoenhard; Anthony J. Fitzpatrick; Arthur Dresner; Aziz Burgy; Carolyn A. Alenci; Charles B. Klein; Dan H. Hoang; Danielle C. Cendrowski; David Ellis Moore; Deirdre M. Dorval; Dominick T. Gattuso; Duane Morris LLP; Emily N. Winfield; Eric H. Weisblatt; Frederick R. Ball; Gary William Lipkin; Jack B. Blumenfeld; Jaclyn C. Levy; Janine A. Carlan; Joel M. Wallace; John C. Phillips , Jr.; Jordana A. Garellek; Joshua T. Morris; Katharine Crawford Lester; Katharine Lester Mowery; Laura A. Lydigsen; Laura D. Hatcher; Mark A. Pacella; Maryellen Noreika; Matt Neiderman; Megan C. Haney; Ralph J. Gabric; Richard J. Berman; Richard L. Horwitz; Robert J. Scheffel; Samuel S. Park; Stephanie L. Donahue; Stephen Yang; Steven J. Fineman; Taniel E. Anderson; Timothy W. Bucknell; Tracey B. Davies; Vincent J. Poppiti; Vincent L. Capuano; Yuezhong Feng
Firms DLA Piper LLP; Duane Morris, LLP; Eckert Seamans Cherin & Mellott, LLC; Friedlander & Gorris, P.A.; Heyman Enerio Gattuso & Hirzel LLP; Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.; Richards, Layton & Finger, PA
Link to Docket External link to docket
Small Molecule Drugs cited in Avanir Pharmaceuticals Inc. v. Actavis South Atlantic LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Avanir Pharmaceuticals Inc. v. Actavis South Atlantic LLC (D. Del. 2011)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 12 disclosures related to U.S. Patent No. 8,227,484 (the '"484 patent") pursuant to Federal …products 1 and the asserted claim(s) of the '484 patent that Defendants 1 allegedly infringe by October…shall produce the file history for the '484 patent pursuant to paragraph 4.a of the £-Discovery…contentions for each asserted claim of the '484 patent, as well as the related invalidating references…references (e.g., publications, manuals, and patents) pursuant to paragraph 4.d of the £-Discovery External link to document
0000-00-00 187 ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (2) Avanir's Initial Claim Chart Relating…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (3) Avanir's Initial Claim Chart Relating…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (4) Avanir's Initial Claim Chart Relating…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; and (5) Avanir's Initial Claim Chart Relating…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484 by Avanir Pharmaceuticals Inc..(Noreika, External link to document
0000-00-00 189 ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (2) Avanir's Amended Initial Claim Chart…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (3) Avanir's Amended Initial Claim Chart…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; (4) Avanir's Amended Initial Claim Chart…ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484; and (5) Avanir's Amended Initial Claim …ANDA Product to the Asserted Claims of U.S. Patent No. 8,227,484 by Avanir Holding Company, Avanir Pharmaceuticals External link to document
0000-00-00 256 found in U.S. Patent Nos. RE38,115 (the '"115 patent") and 7,659,282 (the "'…#39;282 patent"). The '115 patent relates to formulations containing dextromethorphan and …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which… the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification… TERMS I. The '115 Patent Claim 18 ofthe '115 patent, with the disputed terms highlighted External link to document
0000-00-00 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,659,282; RE 38,115. (nms) (… 25 September 2015 1:11-cv-00704 830 Patent None District Court, D. Delaware External link to document
2013-08-09 374 Concerning Alledged Infringement of U.S. Patent No. RE38,115 by Wockhardt Ltd., Wockhardt USA LLC. (Attachments… 25 September 2015 1:11-cv-00704 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.